BIOPROCESS VALIDATION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Bioprocess Validation Market, By Test Type (Extractable Testing Services, Microbiological Testing Services, Physiochemical Testing Services, Integrity Testing Services, and Others (Compatibility Testing Services and Others)), By Process Component (Filter Elements, Media containers and bags, Freezing And Thawing Process Bags, Bioreactors, Transfer Systems, and Others (Mixing Systems and Others)), By End User (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organizations, Academic and Research Institutes, and Other (Clinical Research Organizations and Others)), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Recent Developments:

New product launches:

In January 2019, Sartorius Stedim Biotech, an international pharmaceutical and laboratory equipment supplier, which offers solutions for the biopharmaceutical industry and laboratories, launched ambr 250 modular, an automated mini bioreactor system for bioprocess development applications like cell line screening, process optimization and scale-up modeling

Acquisition and partnerships:

In January 2021, Sartorius AG, an international partner for biopharmaceutical research and industry, acquired a majority stake in CellGenix, a leading global supplier of GMP-grade cell culture components, to expand its cell culture media portfolio
In June 2020, Thermo Fisher Scientific, a biotechnology company, acquired Henogen, a viral vector CDMO, to expand capabilities for cell and gene therapy development and manufacturing

Bioprocess Validation Market Report Snapshots